These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 37515156)

  • 1. Glycemic Dysregulation, Inflammation and Disease Outcomes in Patients Hospitalized with COVID-19: Beyond Diabetes and Obesity.
    Liontos A; Biros D; Kavakli A; Matzaras R; Tsiakas I; Athanasiou L; Samanidou V; Konstantopoulou R; Vagias I; Panteli A; Pappa C; Kolios NG; Nasiou M; Pargana E; Milionis H; Christaki E
    Viruses; 2023 Jun; 15(7):. PubMed ID: 37515156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperglycemia and Correlated High Levels of Inflammation Have a Positive Relationship with the Severity of Coronavirus Disease 2019.
    Zhang W; Li C; Xu Y; He B; Hu M; Cao G; Li L; Wu S; Wang X; Zhang C; Zhao J; Xie J; Xu Z; Li Q; Wang G
    Mediators Inflamm; 2021; 2021():8812304. PubMed ID: 33814982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control?
    Sardu C; D'Onofrio N; Balestrieri ML; Barbieri M; Rizzo MR; Messina V; Maggi P; Coppola N; Paolisso G; Marfella R
    Diabetes Care; 2020 Jul; 43(7):1408-1415. PubMed ID: 32430456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19.
    Vasbinder A; Anderson E; Shadid H; Berlin H; Pan M; Azam TU; Khaleel I; Padalia K; Meloche C; O'Hayer P; Michaud E; Catalan T; Feroze R; Blakely P; Launius C; Huang Y; Zhao L; Ang L; Mikhael M; Mizokami-Stout K; Pennathur S; Kretzler M; Loosen SH; Chalkias A; Tacke F; Giamarellos-Bourboulis EJ; Reiser J; Eugen-Olsen J; Feldman EL; Pop-Busui R; Hayek SS;
    Diabetes Care; 2022 Mar; 45(3):692-700. PubMed ID: 35045184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of COVID 19 pneumonia on hyperglycemia: Is it different from non COVID pneumonia?
    Knox DB; Hirshberg EL; Orme J; Peltan I; Lanspa MJ
    Diabetes Metab Syndr; 2022 Feb; 16(2):102407. PubMed ID: 35074624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperglycemia associated with lymphopenia and disease severity of COVID-19 in type 2 diabetes mellitus.
    Cheng Y; Yue L; Wang Z; Zhang J; Xiang G
    J Diabetes Complications; 2021 Feb; 35(2):107809. PubMed ID: 33288414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Hyperglycemia on Cardiovascular Events and Clinical Outcomes in Patients Hospitalized With COVID-19 Pneumonia.
    Krishnasamy S; Sheikh D; Ali T; Clemons V; Furmanek S; Mohamed Fawzy Abdelhaleem AA; Salunkhe V; Akbar UA; Chlebowy D; Ramirez J; Arnold F
    Endocr Pract; 2022 Aug; 28(8):780-786. PubMed ID: 35671878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study.
    Coppelli A; Giannarelli R; Aragona M; Penno G; Falcone M; Tiseo G; Ghiadoni L; Barbieri G; Monzani F; Virdis A; Menichetti F; Del Prato S;
    Diabetes Care; 2020 Oct; 43(10):2345-2348. PubMed ID: 32788285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between newly diagnosed hyperglycemia/diabetes mellitus, atherogenic index of plasma and obesity in post-COVID-19 syndrome patients.
    Emiroglu C; Dicle M; Yesiloglu C; Gorpelioglu S; Aypak C
    Endocrine; 2024 May; 84(2):470-480. PubMed ID: 38001321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19.
    Calvisi SL; Ramirez GA; Scavini M; Da Prat V; Di Lucca G; Laurenzi A; Gallina G; Cavallo L; Borio G; Farolfi F; Pascali M; Castellani J; Lampasona V; D'Angelo A; Landoni G; Ciceri F; Querini PR; Tresoldi M; Piemonti L
    Metabolism; 2021 Oct; 123():154845. PubMed ID: 34364927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caring for Hospitalized Patients with Diabetes Mellitus, Hyperglycemia, and COVID-19: Bridging the Remaining Knowledge Gaps.
    Wallia A; Prince G; Touma E; El Muayed M; Seley JJ
    Curr Diab Rep; 2020 Nov; 20(12):77. PubMed ID: 33244614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between Hyperglycemia at Hospital Presentation and Hospital Outcomes in COVID-19 Patients with and without Type 2 Diabetes: A Retrospective Cohort Study of Hospitalized Inner-City COVID-19 Patients.
    Charoenngam N; Alexanian SM; Apovian CM; Holick MF
    Nutrients; 2021 Jun; 13(7):. PubMed ID: 34206813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients With Coronavirus Disease 2019.
    Zhang J; Kong W; Xia P; Xu Y; Li L; Li Q; Yang L; Wei Q; Wang H; Li H; Zheng J; Sun H; Xia W; Liu G; Zhong X; Qiu K; Li Y; Wang H; Wang Y; Song X; Liu H; Xiong S; Liu Y; Cui Z; Hu Y; Chen L; Pan A; Zeng T
    Front Endocrinol (Lausanne); 2020; 11():525. PubMed ID: 32754119
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical outcomes in patients with diabetes and stress hyperglycemia that developed SARS-CoV-2 infection.
    Fériz-Bonelo KM; Iriarte-Durán MB; Giraldo O; Parra-Lara LG; Martínez V; Urbano MA; Guzmán G
    Biomedica; 2024 May; 44(Sp. 1):73-88. PubMed ID: 39079143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impact of hyperglycemia on the prognosis of patients hospitalized for severe pneumonia in COVID-19].
    López-Burgos CP; Cruz-Domínguez MDP; López-Zamora B; Medina-García G; Montiel-Cervantes LA; Colorado-Cruz MF; Vera-Lastra O; Montes-Cortés DH; Morales-Montalvo SI; Ordoñez-González I
    Rev Med Inst Mex Seguro Soc; 2023 May; 61(3):335-341. PubMed ID: 37216668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-Hospital Hyperglycemia Is Associated With Worse Outcomes in Patients Admitted With COVID-19.
    Lombardi A; Agarwal S; Schechter C; Tomer Y
    Diabetes Care; 2022 Nov; 45(11):2683-2688. PubMed ID: 36041197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycemic Gap Predicts Mortality in a Large Multicenter Cohort Hospitalized With COVID-19.
    McDonnell ME; Garg R; Gopalakrishnan G; Mitri J; Weinstock RS; Greenfield M; Katta S; Lebastchi J; Palermo NE; Radhakrishnan R; Westcott GP; Johnson M; Simonson DC
    J Clin Endocrinol Metab; 2023 Feb; 108(3):718-725. PubMed ID: 36217580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes.
    Rajpal A; Rahimi L; Ismail-Beigi F
    J Diabetes; 2020 Dec; 12(12):895-908. PubMed ID: 32671936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of simple and cost-effective immuno- haematological markers to predict outcome in hospitalized severe COVID-19 patients, with a focus on diabetes mellitus - A retrospective study in Andhra Pradesh, India.
    Ramesh J; Reddy SLS; Rajesh M; Varghese J
    Diabetes Metab Syndr; 2021; 15(3):739-745. PubMed ID: 33819728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is elevated blood glucose at admission associated with poor outcomes in hospitalized COVID-19 patients?
    Barbosa M; Marques-Sá J; Carvalho C; Fernandes V
    Arch Endocrinol Metab; 2023 Jun; 67(6):e000649. PubMed ID: 37364151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.